Diagnostics

LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore,…

4 months ago

New Data Reveals BD’s Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion

FRANKLIN LAKES, N.J., Sept. 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,…

4 months ago

Angle PLC Announces Half-year Report

Interim Results for the six months ended 30 June 2024LARGE PHARMA STRATEGY IMPLEMENTED SUCCESSFULLYThree Large Pharma contracts secured each with…

4 months ago

RIVANNA secures patent for groundbreaking ultrasound-guided needle insertion system

CHARLOTTESVILLE, Va., Sept. 25, 2024 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical solutions, announced the acquisition of a groundbreaking…

4 months ago

Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management

SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ -- Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding…

4 months ago

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Invests More Than $7 Million in C2N Diagnostics’ Blood Tests

New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics.Blood tests will be key to…

4 months ago

Sanner Group acquires Gilero to expand its global medical device offering

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite…

4 months ago

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development…

4 months ago

Novel Protocol with Wesper Cuts Hypoglossal Nerve Stimulation Titration Time by 45%, Enhancing Patient Outcomes

NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Wesper, a leader in home-based sleep diagnostics, has announced significant findings from a…

4 months ago

CS Genetics Appoints Bill Colston, PhD, as Chief Executive Officer

Experienced life-science entrepreneur to drive next generation of single cell biology SAN DIEGO and CAMBRIDGE, England, Sept. 24, 2024 /PRNewswire/…

4 months ago